This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.
Testing the association between copy number variation 53 focal events and 8 clinical features across 117 patients, no significant finding detected with Q value < 0.25.
-
No focal cnvs related to clinical features.
Clinical Features |
Time to Death |
AGE |
NEOPLASM DISEASESTAGE |
PATHOLOGY T STAGE |
PATHOLOGY N STAGE |
PATHOLOGY M STAGE |
GENDER |
COMPLETENESS OF RESECTION |
||
nCNV (%) | nWild-Type | logrank test | t-test | Chi-square test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
AMP PEAK 1(1P22 3) MUTATION ANALYSIS | 31 (26%) | 86 |
0.372 (1.00) |
0.439 (1.00) |
0.248 (1.00) |
0.814 (1.00) |
0.532 (1.00) |
0.0785 (1.00) |
0.832 (1.00) |
0.0671 (1.00) |
AMP PEAK 2(1Q22) MUTATION ANALYSIS | 86 (74%) | 31 |
0.056 (1.00) |
0.381 (1.00) |
0.665 (1.00) |
0.66 (1.00) |
1 (1.00) |
0.894 (1.00) |
0.388 (1.00) |
0.692 (1.00) |
AMP PEAK 3(1Q42 3) MUTATION ANALYSIS | 79 (68%) | 38 |
0.0831 (1.00) |
0.432 (1.00) |
0.138 (1.00) |
0.0269 (1.00) |
0.548 (1.00) |
1 (1.00) |
0.543 (1.00) |
0.852 (1.00) |
AMP PEAK 4(2P24 1) MUTATION ANALYSIS | 26 (22%) | 91 |
0.968 (1.00) |
0.433 (1.00) |
0.186 (1.00) |
0.113 (1.00) |
0.108 (1.00) |
0.305 (1.00) |
0.648 (1.00) |
0.529 (1.00) |
AMP PEAK 5(2Q31 2) MUTATION ANALYSIS | 27 (23%) | 90 |
0.355 (1.00) |
0.443 (1.00) |
0.163 (1.00) |
0.398 (1.00) |
0.508 (1.00) |
0.581 (1.00) |
0.112 (1.00) |
0.576 (1.00) |
AMP PEAK 6(3Q26 31) MUTATION ANALYSIS | 22 (19%) | 95 |
0.216 (1.00) |
0.495 (1.00) |
0.723 (1.00) |
0.455 (1.00) |
0.345 (1.00) |
0.371 (1.00) |
0.808 (1.00) |
1 (1.00) |
AMP PEAK 7(5P15 33) MUTATION ANALYSIS | 58 (50%) | 59 |
0.665 (1.00) |
0.904 (1.00) |
0.151 (1.00) |
0.104 (1.00) |
0.605 (1.00) |
0.0795 (1.00) |
0.849 (1.00) |
1 (1.00) |
AMP PEAK 8(5Q35 3) MUTATION ANALYSIS | 43 (37%) | 74 |
0.387 (1.00) |
0.378 (1.00) |
0.549 (1.00) |
0.681 (1.00) |
0.547 (1.00) |
1 (1.00) |
0.239 (1.00) |
0.193 (1.00) |
AMP PEAK 9(6P25 2) MUTATION ANALYSIS | 49 (42%) | 68 |
0.132 (1.00) |
0.688 (1.00) |
0.454 (1.00) |
0.326 (1.00) |
1 (1.00) |
0.343 (1.00) |
0.181 (1.00) |
0.851 (1.00) |
AMP PEAK 10(6P21 1) MUTATION ANALYSIS | 49 (42%) | 68 |
0.46 (1.00) |
0.406 (1.00) |
0.324 (1.00) |
0.937 (1.00) |
0.286 (1.00) |
0.252 (1.00) |
0.181 (1.00) |
0.851 (1.00) |
AMP PEAK 11(7Q21 2) MUTATION ANALYSIS | 45 (38%) | 72 |
0.632 (1.00) |
0.0497 (1.00) |
0.546 (1.00) |
0.489 (1.00) |
0.28 (1.00) |
0.691 (1.00) |
0.557 (1.00) |
0.46 (1.00) |
AMP PEAK 12(8Q13 1) MUTATION ANALYSIS | 61 (52%) | 56 |
0.725 (1.00) |
0.759 (1.00) |
0.176 (1.00) |
0.37 (1.00) |
0.615 (1.00) |
0.91 (1.00) |
0.00393 (1.00) |
0.773 (1.00) |
AMP PEAK 13(8Q24 13) MUTATION ANALYSIS | 70 (60%) | 47 |
0.553 (1.00) |
0.912 (1.00) |
0.36 (1.00) |
0.953 (1.00) |
0.567 (1.00) |
1 (1.00) |
0.00626 (1.00) |
0.956 (1.00) |
AMP PEAK 14(9Q34 2) MUTATION ANALYSIS | 15 (13%) | 102 |
0.76 (1.00) |
0.268 (1.00) |
0.19 (1.00) |
0.476 (1.00) |
0.284 (1.00) |
0.478 (1.00) |
0.783 (1.00) |
0.0348 (1.00) |
AMP PEAK 15(10P15 1) MUTATION ANALYSIS | 24 (21%) | 93 |
0.37 (1.00) |
0.469 (1.00) |
0.19 (1.00) |
0.073 (1.00) |
1 (1.00) |
0.334 (1.00) |
0.814 (1.00) |
0.922 (1.00) |
AMP PEAK 16(11Q13 3) MUTATION ANALYSIS | 21 (18%) | 96 |
0.98 (1.00) |
0.614 (1.00) |
0.0639 (1.00) |
0.0099 (1.00) |
1 (1.00) |
0.247 (1.00) |
0.805 (1.00) |
0.0572 (1.00) |
AMP PEAK 17(12Q23 1) MUTATION ANALYSIS | 22 (19%) | 95 |
0.792 (1.00) |
0.103 (1.00) |
0.123 (1.00) |
0.259 (1.00) |
0.457 (1.00) |
0.307 (1.00) |
0.224 (1.00) |
0.257 (1.00) |
AMP PEAK 18(13Q32 3) MUTATION ANALYSIS | 22 (19%) | 95 |
0.205 (1.00) |
0.868 (1.00) |
0.93 (1.00) |
0.792 (1.00) |
0.403 (1.00) |
0.855 (1.00) |
0.466 (1.00) |
0.133 (1.00) |
AMP PEAK 19(15Q26 3) MUTATION ANALYSIS | 19 (16%) | 98 |
0.344 (1.00) |
0.594 (1.00) |
0.918 (1.00) |
0.282 (1.00) |
1 (1.00) |
1 (1.00) |
0.195 (1.00) |
1 (1.00) |
AMP PEAK 20(17P11 2) MUTATION ANALYSIS | 18 (15%) | 99 |
0.578 (1.00) |
0.538 (1.00) |
0.0742 (1.00) |
0.0777 (1.00) |
1 (1.00) |
0.243 (1.00) |
0.795 (1.00) |
0.0466 (1.00) |
AMP PEAK 21(17Q23 1) MUTATION ANALYSIS | 50 (43%) | 67 |
0.598 (1.00) |
0.604 (1.00) |
0.287 (1.00) |
0.69 (1.00) |
1 (1.00) |
0.348 (1.00) |
0.848 (1.00) |
0.27 (1.00) |
AMP PEAK 22(17Q25 3) MUTATION ANALYSIS | 54 (46%) | 63 |
0.258 (1.00) |
0.981 (1.00) |
0.451 (1.00) |
0.255 (1.00) |
1 (1.00) |
0.33 (1.00) |
0.126 (1.00) |
0.0797 (1.00) |
AMP PEAK 23(19P13 12) MUTATION ANALYSIS | 32 (27%) | 85 |
0.679 (1.00) |
0.467 (1.00) |
0.101 (1.00) |
0.693 (1.00) |
0.556 (1.00) |
0.0156 (1.00) |
0.133 (1.00) |
0.346 (1.00) |
AMP PEAK 24(19Q13 11) MUTATION ANALYSIS | 38 (32%) | 79 |
0.596 (1.00) |
0.638 (1.00) |
0.0067 (1.00) |
0.0322 (1.00) |
1 (1.00) |
0.0123 (1.00) |
0.311 (1.00) |
0.216 (1.00) |
AMP PEAK 25(20Q13 33) MUTATION ANALYSIS | 43 (37%) | 74 |
0.846 (1.00) |
0.117 (1.00) |
0.239 (1.00) |
0.959 (1.00) |
0.28 (1.00) |
0.244 (1.00) |
0.323 (1.00) |
0.532 (1.00) |
DEL PEAK 1(1P36 32) MUTATION ANALYSIS | 54 (46%) | 63 |
0.398 (1.00) |
0.196 (1.00) |
0.592 (1.00) |
0.0547 (1.00) |
0.573 (1.00) |
0.403 (1.00) |
0.342 (1.00) |
0.209 (1.00) |
DEL PEAK 2(1P35 2) MUTATION ANALYSIS | 44 (38%) | 73 |
0.545 (1.00) |
0.128 (1.00) |
0.234 (1.00) |
0.365 (1.00) |
0.0355 (1.00) |
0.12 (1.00) |
0.694 (1.00) |
0.361 (1.00) |
DEL PEAK 3(2Q22 1) MUTATION ANALYSIS | 13 (11%) | 104 |
0.124 (1.00) |
0.832 (1.00) |
0.593 (1.00) |
0.138 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.734 (1.00) |
DEL PEAK 4(2Q37 3) MUTATION ANALYSIS | 23 (20%) | 94 |
0.517 (1.00) |
0.962 (1.00) |
0.602 (1.00) |
0.213 (1.00) |
0.508 (1.00) |
0.612 (1.00) |
0.149 (1.00) |
0.917 (1.00) |
DEL PEAK 5(3P13) MUTATION ANALYSIS | 20 (17%) | 97 |
0.423 (1.00) |
0.733 (1.00) |
0.126 (1.00) |
0.143 (1.00) |
0.43 (1.00) |
0.282 (1.00) |
0.217 (1.00) |
0.742 (1.00) |
DEL PEAK 6(4P16 1) MUTATION ANALYSIS | 22 (19%) | 95 |
0.437 (1.00) |
0.861 (1.00) |
0.241 (1.00) |
0.927 (1.00) |
0.0722 (1.00) |
0.438 (1.00) |
0.333 (1.00) |
0.222 (1.00) |
DEL PEAK 7(4Q25) MUTATION ANALYSIS | 54 (46%) | 63 |
0.212 (1.00) |
0.42 (1.00) |
0.461 (1.00) |
0.844 (1.00) |
0.0976 (1.00) |
0.33 (1.00) |
0.849 (1.00) |
0.254 (1.00) |
DEL PEAK 8(4Q35 1) MUTATION ANALYSIS | 49 (42%) | 68 |
0.0255 (1.00) |
0.279 (1.00) |
0.695 (1.00) |
1 (1.00) |
0.573 (1.00) |
0.252 (1.00) |
0.699 (1.00) |
0.336 (1.00) |
DEL PEAK 9(5Q23 1) MUTATION ANALYSIS | 16 (14%) | 101 |
0.123 (1.00) |
0.714 (1.00) |
0.465 (1.00) |
0.116 (1.00) |
0.345 (1.00) |
1 (1.00) |
0.782 (1.00) |
0.695 (1.00) |
DEL PEAK 10(6Q16 3) MUTATION ANALYSIS | 42 (36%) | 75 |
0.798 (1.00) |
0.602 (1.00) |
0.499 (1.00) |
0.431 (1.00) |
0.28 (1.00) |
0.336 (1.00) |
0.429 (1.00) |
0.644 (1.00) |
DEL PEAK 11(6Q26) MUTATION ANALYSIS | 47 (40%) | 70 |
0.724 (1.00) |
0.64 (1.00) |
0.414 (1.00) |
0.315 (1.00) |
0.561 (1.00) |
0.0288 (1.00) |
1 (1.00) |
0.665 (1.00) |
DEL PEAK 12(8P23 2) MUTATION ANALYSIS | 75 (64%) | 42 |
0.0603 (1.00) |
0.0376 (1.00) |
0.414 (1.00) |
0.649 (1.00) |
0.269 (1.00) |
0.834 (1.00) |
0.429 (1.00) |
1 (1.00) |
DEL PEAK 13(8P11 22) MUTATION ANALYSIS | 60 (51%) | 57 |
0.0487 (1.00) |
0.0345 (1.00) |
0.397 (1.00) |
0.526 (1.00) |
0.0976 (1.00) |
0.213 (1.00) |
0.572 (1.00) |
1 (1.00) |
DEL PEAK 14(9P21 3) MUTATION ANALYSIS | 45 (38%) | 72 |
0.4 (1.00) |
0.92 (1.00) |
0.0878 (1.00) |
0.16 (1.00) |
0.55 (1.00) |
0.038 (1.00) |
0.557 (1.00) |
0.0448 (1.00) |
DEL PEAK 15(9Q34 3) MUTATION ANALYSIS | 43 (37%) | 74 |
0.998 (1.00) |
0.573 (1.00) |
0.151 (1.00) |
0.561 (1.00) |
0.05 (1.00) |
0.1 (1.00) |
0.554 (1.00) |
0.467 (1.00) |
DEL PEAK 16(10Q23 31) MUTATION ANALYSIS | 36 (31%) | 81 |
0.95 (1.00) |
0.964 (1.00) |
0.14 (1.00) |
0.104 (1.00) |
0.211 (1.00) |
0.584 (1.00) |
1 (1.00) |
0.139 (1.00) |
DEL PEAK 17(11Q23 3) MUTATION ANALYSIS | 24 (21%) | 93 |
0.99 (1.00) |
0.0236 (1.00) |
0.316 (1.00) |
0.236 (1.00) |
0.0952 (1.00) |
0.862 (1.00) |
0.645 (1.00) |
0.421 (1.00) |
DEL PEAK 18(12P12 1) MUTATION ANALYSIS | 26 (22%) | 91 |
0.103 (1.00) |
0.923 (1.00) |
0.234 (1.00) |
0.74 (1.00) |
0.121 (1.00) |
0.565 (1.00) |
0.82 (1.00) |
0.106 (1.00) |
DEL PEAK 19(12Q24 33) MUTATION ANALYSIS | 20 (17%) | 97 |
0.451 (1.00) |
0.461 (1.00) |
0.0585 (1.00) |
0.441 (1.00) |
1 (1.00) |
0.144 (1.00) |
0.217 (1.00) |
1 (1.00) |
DEL PEAK 20(13Q14 2) MUTATION ANALYSIS | 54 (46%) | 63 |
0.129 (1.00) |
0.614 (1.00) |
0.285 (1.00) |
0.00179 (0.758) |
1 (1.00) |
0.753 (1.00) |
0.342 (1.00) |
0.661 (1.00) |
DEL PEAK 21(13Q22 2) MUTATION ANALYSIS | 43 (37%) | 74 |
0.533 (1.00) |
0.115 (1.00) |
0.572 (1.00) |
0.00143 (0.608) |
0.548 (1.00) |
0.834 (1.00) |
0.323 (1.00) |
0.57 (1.00) |
DEL PEAK 22(14Q23 3) MUTATION ANALYSIS | 41 (35%) | 76 |
0.759 (1.00) |
0.978 (1.00) |
0.239 (1.00) |
0.235 (1.00) |
1 (1.00) |
0.545 (1.00) |
0.69 (1.00) |
0.251 (1.00) |
DEL PEAK 23(16Q23 1) MUTATION ANALYSIS | 50 (43%) | 67 |
0.0629 (1.00) |
0.203 (1.00) |
0.527 (1.00) |
0.378 (1.00) |
0.615 (1.00) |
0.912 (1.00) |
0.25 (1.00) |
0.0773 (1.00) |
DEL PEAK 24(17P13 3) MUTATION ANALYSIS | 64 (55%) | 53 |
0.177 (1.00) |
0.231 (1.00) |
0.229 (1.00) |
0.566 (1.00) |
1 (1.00) |
0.16 (1.00) |
0.705 (1.00) |
0.184 (1.00) |
DEL PEAK 25(17P11 2) MUTATION ANALYSIS | 64 (55%) | 53 |
0.355 (1.00) |
0.895 (1.00) |
0.285 (1.00) |
0.343 (1.00) |
0.262 (1.00) |
0.911 (1.00) |
0.449 (1.00) |
0.25 (1.00) |
DEL PEAK 26(18Q21 2) MUTATION ANALYSIS | 24 (21%) | 93 |
0.142 (1.00) |
0.217 (1.00) |
0.616 (1.00) |
0.934 (1.00) |
0.43 (1.00) |
0.543 (1.00) |
0.167 (1.00) |
0.922 (1.00) |
DEL PEAK 27(19P13 3) MUTATION ANALYSIS | 27 (23%) | 90 |
0.873 (1.00) |
0.497 (1.00) |
0.146 (1.00) |
0.153 (1.00) |
1 (1.00) |
0.153 (1.00) |
1 (1.00) |
0.858 (1.00) |
DEL PEAK 28(22Q13 32) MUTATION ANALYSIS | 30 (26%) | 87 |
0.112 (1.00) |
0.883 (1.00) |
0.747 (1.00) |
0.118 (1.00) |
1 (1.00) |
0.347 (1.00) |
0.277 (1.00) |
0.163 (1.00) |
-
Copy number data file = transformed.cor.cli.txt
-
Clinical data file = LIHC-TP.clin.merged.picked.txt
-
Number of patients = 117
-
Number of significantly focal cnvs = 53
-
Number of selected clinical features = 8
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R
For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.